A Study of Avelumab in Combination With Axitinib In Non-Small Cell Lung Cancer (NSCLC) or Urothelial Cancer (Javelin Medley VEGF)
Public ClinicalTrials.gov record NCT03472560. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A PHASE 2, OPEN LABEL STUDY TO EVALUATE SAFETY AND CLINICAL ACTIVITY OF AVELUMAB (BAVENCIO (REGISTERED)) IN COMBINATION WITH AXITINIB (INLYTA (REGISTERED)) IN PATIENTS WITH ADVANCED OR METASTATIC PREVIOUSLY TREATED NON-SMALL CELL LUNG CANCER OR TREATMENT NAÏVE CISPLATIN-INELIGIBLE UROTHELIAL CANCER JAVELIN MEDLEY VEGF
Study identification
- NCT ID
- NCT03472560
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Pfizer
- Industry
- Enrollment
- 61 participants
Conditions and interventions
Conditions
Interventions
- Avelumab (MSB0010718C) Drug
- Axitinib (AG-013736) Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 1, 2018
- Primary completion
- Feb 8, 2023
- Completion
- Feb 8, 2023
- Last update posted
- Apr 8, 2024
2018 – 2023
United States locations
- U.S. sites
- 14
- U.S. states
- 5
- U.S. cities
- 11
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Arizona Oncology Associates- Saguaro Cancer Center | Glendale | Arizona | 85308 | — |
| Arizona Oncology Associates | Goodyear | Arizona | 85395 | — |
| Arizona Oncology Associates- Biltmore Cancer Center | Phoenix | Arizona | 85016 | — |
| Arizona Oncology Associates- Deer Valley Cancer Center | Phoenix | Arizona | 85027 | — |
| Arizona Oncology Associates- East Valley Cancer Center | Tempe | Arizona | 85281 | — |
| The Oncology Institute of Hope and Innovation | Glendale | California | 91204 | — |
| The Oncology Institute of Hope and Innovation | Long Beach | California | 90805 | — |
| The Oncology Institute of Hope and Innovation | Santa Ana | California | 92705 | — |
| The Oncology Institute of Hope and Innovation | Whittier | California | 90602 | — |
| Oncology Hematology Associates | Springfield | Missouri | 65807 | — |
| Oncology Hematology West, PC dba Nebraska Cancer Specialists | Omaha | Nebraska | 68114 | — |
| Oncology Hematology West, PC dba Nebraska Cancer Specialists | Omaha | Nebraska | 68130 | — |
| Saint Francis Hospital | Greenville | South Carolina | 29601 | — |
| Saint Francis Hospital Cancer Center | Greenville | South Carolina | 29607 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 25 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03472560, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 8, 2024 · Synced Jun 25, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT03472560 live on ClinicalTrials.gov.